Fella Health names two pharmacies and puts lab work and medication inside its published NAD+ programme fee. It also renders a content-management placeholder reading "REMOVE tirzepatide" as visible text on every pricing card it publishes, and publishes no price at all for either weight-loss molecule.
What Fella Health charges
NAD+: $129/mo — the monthly plan; six months paid in full is $594, which the seller restates as $99 a month
Fella Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The NAD+ programme fee is the one thing here that is fully priced
Its NAD+ page publishes a monthly plan and a six-month prepaid total, and restates that total as an effective monthly rate; both are recorded here.
The fee includes the medication and, in the seller's own words, "Free lab work for your convenience (if needed)" with "no hidden charges".
Its home page advertises the prepaid rate as the headline monthly figure, which it is not. Read the plan page, not the banner.
Neither weight-loss molecule has a price
Its semaglutide and tirzepatide cards carry no figure at all.
The only weight-loss number anywhere is a bundled daily floor, which its own copy attaches to "everything you need to lose weight: GLP-1 medications, health assessments, and medical support" — both molecules and several services besides.
A floor over a bundle is not a price for a drug, so nothing is filed for either one.
An unfinished page and a layout that misleads
A content placeholder reading "REMOVE tirzepatide" renders as visible text on every pricing card on the home page and the treatments page. It is not a stray comment in the markup; a reader sees it.
On that same treatments page each price is printed after its own product's bullet list and immediately before the next product's name, so a figure sits closer to the product it does not belong to.
The NAD+ card at the end of that page carries no price at all, which is why the figures here were read on the NAD+ page itself.
What it says in its own words
It states plainly that "While compounded medications are not FDA-approved, they are regulated at the state and federal level and must meet important safety and quality requirements" — its own words, printed rather than implied.
It names Strive Pharmacy and Red Rock Home Pharmacy as the pharmacies preparing its medicines.
It makes no state-coverage claim. Its state pages are marketing pages rather than an availability list, so no states are recorded here.
Who it's for
Readers buying NAD+ who want labs and medication inside one published fee.
Buyers who want the dispensing pharmacies named before they order.
Shoppers who want a prepaid total printed beside its effective monthly rate.
Anyone who wants the seller to say in its own words that compounded medicines are not FDA-approved.
Who should look elsewhere
Buyers shopping either weight-loss molecule on price, since neither has one.
Readers who take an unfinished placeholder on a pricing card as a sign of how the rest is run.
Anyone who needs to know whether the service reaches their state.
Shoppers who want a dose stated beside the NAD+ figure.
Strengths
Names two dispensing pharmacies, one with a contact address
Includes lab work and medication in the published NAD+ programme fee
States in its own words that compounded medicines are not FDA-approved
Prints the prepaid total beside the effective monthly rate
Trade-offs
Renders a content-management placeholder reading "REMOVE tirzepatide" as visible text on its pricing cards
Publishes no price for either weight-loss molecule, only a bundled daily floor covering both
Its treatments page prints each price before the next product's name, which is easy to misread
Makes no state-coverage claim; its state pages are marketing pages, not an availability list
How we verified this
Read the NAD+ figures on the NAD+ page itself rather than the treatments page, because that page's last card carries no price and its layout prints each figure beside the wrong product name.
Confirmed the weight-loss cards carry no figure, read the bundled daily floor in full, and filed nothing for either molecule.
Confirmed the placeholder text is rendered as visible text on the pricing cards rather than sitting only in the markup.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand against the live federal warning-letter table through a matcher that normalises both the query and the filed company name before comparing, and attached nothing: the table's nearest hit is "Fella Group LLC", a 2022 Foreign Supplier Verification Program matter, which is a food-import programme and a different company from this seller, whose entity is Aios Inc. doing business as Fella.
A provider to compare Fella Health against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
No. The screen did surface a similarly named recipient, "Fella Group LLC", but that is a 2022 food-import matter against a different company and it is not attached to this seller. A name match is not an entity match.
What does semaglutide or tirzepatide cost here?
The site does not say. Its GLP-1 cards carry no figure, and the only weight-loss number is a bundled daily floor covering both molecules plus assessments and support.
Are labs included?
Yes, for the NAD+ programme. The seller's own copy offers free lab work if needed and says the medication is included with no hidden charges.
Why does a pricing card say "REMOVE tirzepatide"?
It is an unfilled content-management placeholder that ships as visible text on the pricing cards on both the home page and the treatments page. It appears to be an editing note left in the published page.
Fella Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.